1.
Molecular Docking and ADMET Profiling of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin from Dalbergia sissoo: In Silico Prediction in Antidiabetic Potential. Int. J. Pharm. Sci. Drug Res. [Internet]. 2024 Sep. 30 [cited 2025 Oct. 15];16(5):841-54. Available from: https://ijpsdronline.com/index.php/journal/article/view/9988